Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Am J Gastroenterol. 2022 Jun 10;117(9):1462–1470. doi: 10.14309/ajg.0000000000001869

Figure 2a-. Seroprevalence of anti-HEV IgG in DILIN patients enrolled in the first 8 years of the study compared to more recently enrolled patients.

Figure 2a-

The seroprevalence of anti-HEV IgG increased in both cohorts with subject age but overall likelihood of having prior HEV infection was consistently lower in the later compared to the earlier era.